Efficacy of Platelet-rich Plasma in Management of Anosmia

Launched by SOHAG UNIVERSITY · Apr 8, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of Platelet-rich Plasma (PRP) as a potential treatment for anosmia, which is the loss of the sense of smell. Anosmia can happen for various reasons, including damage from infections or injuries, and it can significantly affect a person's quality of life. Currently, there are limited treatment options available, and many people do not fully recover their sense of smell. The researchers hope that PRP, which is made from the patient's own blood and has healing properties, might help improve or restore the sense of smell in those affected by anosmia.

To be eligible for the trial, participants must be between the ages of 18 and 50 and have a specific smell test score indicating anosmia. They should not have any nasal blockages or other conditions that could interfere with the study. If you qualify and decide to participate, you can expect to receive PRP treatment and be monitored for improvements in your sense of smell. This trial is still in the planning stages and has not started recruiting participants yet, but it represents a promising avenue for those struggling with anosmia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • sex:both gender.
• • UPSIT score up to 10 of 40
• • all patients who suffer from anosmia
• • normal airway passage
• • CT free of any sinonasal obstrucive lesions.
• Exclusion Criteria:
• • Age: below 18 years old and above 50years old.
• • All patients with bilateral nasal obstruction related to chronic sinusitis, bilateral nasal polyposis,septum ,turbinate hypertrophy,tumors.
• • UPSIT score more than 10 of 40.
• • Traumatic causes of anosmia.
• • All patients with medical history of blood diseases and diabetic and hypertensive patients.
• • any medical treatment affect coagulation or bone marrow for 2 weeks prior to testing ..